WVE
WAVE Life Sciences Ltd
Price:  
15.41 
USD
Volume:  
786,060.00
Singapore | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

WVE WACC - Weighted Average Cost of Capital

The WACC of WAVE Life Sciences Ltd (WVE) is 6.1%.

The Cost of Equity of WAVE Life Sciences Ltd (WVE) is 7.25%.
The Cost of Debt of WAVE Life Sciences Ltd (WVE) is 5.00%.

Range Selected
Cost of equity 5.70% - 8.80% 7.25%
Tax rate 0.30% - 0.50% 0.40%
Cost of debt 5.00% - 5.00% 5.00%
WACC 5.3% - 6.9% 6.1%
WACC

WVE WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.4 0.71
Additional risk adjustments 0.0% 0.5%
Cost of equity 5.70% 8.80%
Tax rate 0.30% 0.50%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 5.3% 6.9%
Selected WACC 6.1%